- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT05591196
Recuperación motora de manos y brazos mediante estimulación eléctrica no invasiva de la médula espinal después de un accidente cerebrovascular (HARNESS)
The recovery from a stroke is often incomplete. It is the leading cause of acquired permanent disability in the adult population. Persistent functional loss of the hand and arm contributes significantly to disability. However, the current standard of care to treat hand and arm movements are inadequate. There is an urgent need for innovative and effective therapies for recovery of the upper limb after stroke.
Growing evidence shows that electrical spinal cord stimulation, combined with activity-dependent rehabilitation, enables voluntary movement of paralyzed muscles in some neurologic disorders, such as spinal cord injury. The investigators hypothesize that spinal networks that lost control after stroke can be activated by non-invasive electrical stimulation of the spinal cord to improve functional recovery.
The aims of the study are:
- to determine the improvements in hand and arm function that result from the combined application of non-invasive spinal stimulation and activity-based rehabilitation. Surface electrodes placed over the skin of the neck will be used for non-invasive electrical stimulation of the spinal cord. Functional task practice will be used for activity-dependent rehabilitation,
- to evaluate long-lasting benefits to hand and arm function that persist beyond the period of spinal stimulation.
Descripción general del estudio
Estado
Intervención / Tratamiento
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Fatma Inanici
- Número de teléfono: 206-787-2692
- Correo electrónico: finanici@uw.edu
Ubicaciones de estudio
-
-
Washington
-
Seattle, Washington, Estados Unidos, 98105
- Reclutamiento
- University of Washington
-
Sub-Investigador:
- Fatma Inanici, MD, PhD
-
Investigador principal:
- Chet T Moritz, PhD
-
Contacto:
- Fatma Inanici, MD, Ph.D.
- Número de teléfono: 2067872692
- Correo electrónico: finanici@uw.edu
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Radiologically documented single ischemic stroke resulted in hemiplegia/hemiparesis
- At least six months post-stroke
- Upper Extremity Fugl-Meyer Assessment score "moderate" or "moderate-mild" (29-53 inclusive out of 66) at the screening visit
- Medically and neurologically stable, as determined by medical history and documented physical examination
- For women of childbearing potential, a negative over-the-counter pregnancy test at study entry and willingness to practice adequate contraception during the study
- Ability to attend sessions three times per week
- Adequate social support to participate in all intervention and baseline, follow-up assessment sessions throughout eight months.
- Ability to read, comprehend and speak English
Exclusion Criteria:
- Hemorrhagic stroke
- History of multiple strokes
- Active implanted stimulator (e.g., pacemaker, vagus nerve stimulator, cochlear implant, etc.) or baclofen pump
- Aphasia or any other deficit in communication that interferes with reasonable study participation
- Moderate to severe cognitive impairment
- Presence of neglect (inability to perceive or awareness of, or loss of attention to the weaker half of the body)
- Severe spasticity in the upper limb
- Taking baclofen more than 30 mg/day
- Change in baclofen dose within four weeks before enrollment
- Receiving benzodiazepines, dantrolene, tizanidine, anticoagulant, or antiepileptic medication
- Botulinum toxin injection to the upper limb muscles within six months before enrollment
- Severe joint contractures in the affected hand and arm
- History of spontaneous seizure that had occurred one month or longer after the stroke
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación cruzada
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Comparador activo: Activity Based Rehabilitation
Activity Based Rehabilitation is comprised of intensive, progressive, functional task practice. The protocol consists of repetitive activities of gross upper limb movement, isolated finger movements, bimanual task performance, simple and complex pinch, and grip performance. Several activities with various difficulty levels are designated for each category, and the participant will perform 1-2 activities within each category in each rehabilitation session. Rehabilitation sessions will be three times per week, 90 minutes per session for six weeks (total of 18 sessions). |
Exercise therapy targeting paralyzed hand and arm |
|
Experimental: Non-invasive Electrical Spinal Cord Stimulation + Activity Based Rehabilitation
Non-invasive electrical spinal cord stimulation will be performed using surface electrodes placed over the skin of the neck. Biphasic rectangular pulses of 1 millisecond per phase duration will be delivered with a 10 kiloHertz overlapping frequency and between 20-120 Hertzz burst frequency. Non-invasive electrical spinal cord stimulation will be paired with Activity Based Rehabilitation sessions. Stimulation plus rehabilitation sessions will be three times per week, 90 minutes per session for six weeks (total of 18 sessions). |
Exercise therapy targeting paralyzed hand and arm Electrical stimulation of the spinal cord using surface electrodes |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change from baseline - Fugl-Meyer assessment of the upper limb
Periodo de tiempo: "Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
|
The clinician-administered a stroke-specific, performance-based impairment scale. It assesses movement function, sensation, joint range of motion, and pain. The score ranges from 0 to 66. Higher scores indicate better outcomes. |
"Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
|
|
Change from baseline - Pinch and grip force
Periodo de tiempo: "Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
|
Measurement of hand strengths using a dynamometry. |
"Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
|
|
Change from baseline - Modified Ashworth Scale
Periodo de tiempo: "Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
|
Clinician-administered test for resistance of a joint to passive movement. This scale grades muscle tone/spasticity. The score ranges from 0 to 4. Higher scores indicate worse outcomes. |
"Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
|
|
Change from baseline - Wolf Motor Function Test
Periodo de tiempo: "Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
|
Quantifies upper limb motor ability through timed and functional tasks. The score range is 0-75; higher scores denote better function. |
"Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change from baseline - Action Research Arm Test
Periodo de tiempo: "Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
|
Clinician-administered observational measure to assess upper extremity performance, such as coordination, dexterity, and functioning, in stroke recovery. |
"Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
|
|
Change from baseline - Box and Blocks Test
Periodo de tiempo: "Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
|
Participants move, one by one, the maximum number of blocks from one compartment of a box to another of equal size within 60 seconds. Measures gross manual dexterity. |
"Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
|
|
Change from baseline - Revised Nottingham Sensory Assessment
Periodo de tiempo: "Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
|
A standardized scale for assessing sensory impairment in stroke patients. Tactile sensation, proprioception, stereognosis, and two-point discrimination are evaluated. |
"Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
|
|
Change from baseline - Stroke Impact Scale
Periodo de tiempo: "Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
|
A self-report questionnaire that evaluates disability and health-related quality of life after stroke. The questionnaire consists of 8 domains: strength, memory and thinking, emotion, communication, activities of daily living, mobility, hand function, and participation/role function. The score ranges from 0 to 100. Higher scores indicate better outcomes. |
"Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
|
|
Change from baseline - Short Form-36
Periodo de tiempo: "Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
|
A self-report health survey questionnaire. The score range from 0 to 100. The higher the score, the better the outcome. |
"Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
|
|
Change from baseline - Patients Global Impression of Change
Periodo de tiempo: "Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
|
A self-report measure that reflects the participant's belief about the efficacy of treatment: the participant chooses the level of improvement and their functional status between much worse, worse, no change, improved and much improved, compared to the baseline. |
"Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
|
|
Change from baseline - H-reflex test
Periodo de tiempo: "Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
|
Electrophysiologic evaluation of the reflex response triggered on the motor nerves when sensory fibers in the peripheral nerve are stimulated. |
"Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
|
|
Change from baseline - Somatosensory evoked potentials test
Periodo de tiempo: "Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
|
Electrophysiologic evaluation of sensory pathways between the brain and the limb. |
"Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
|
|
Change from baseline - Spinally evoked motor potentials test
Periodo de tiempo: "Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
|
Electrophysiologic evaluation of motor pathways between the central nervous system and the muscles. |
"Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Chet Moritz, PhD, University of Washington
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- STUDY00015990
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
producto fabricado y exportado desde los EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .